Effects of hydroxyurea on extrachromosomal DNA in patients with advanced ovarian carcinomas.

This study showed that, in some circumstances, a noncytotoxic dose of hydroxyurea given to patients with ovarian cancer can decrease the number of metaphase spreads containing dmins in cancer cells.